Repaglinide 33342-0248-11
- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 22, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA207209
Need to source Repaglinide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Repaglinide | .5 mg/1 |
Drug Class
Glinide [EPC]Glinide [EPC]Potassium Channel Antagonists [MoA]
Selected Package
33342-0248-11Selected100 TABLET in 1 BOTTLE (33342-248-11)
Other packages for this product(1)
1000 TABLET in 1 BOTTLE (33342-248-44)